PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
2 hedge funds and large institutions have $16K invested in PAVmed Inc. Warrant in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
64% less capital invested
Capital invested by funds: $44K → $16K (-$28K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
-$14.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.48K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCS
1
Levin Capital Strategies
New York
| $16K | -$14.3K | -30,356 | -45% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$1.48K | -3,149 | -80% |
|
PAVMW Hedge Fund Activity: Q1 2018 in Review
2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q1 2018, worth a combined $16K — down 64% from $44K a quarter earlier.
Fund positioning in PAVMW was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Levin Capital Strategies, cutting an estimated $14.3K.
- 2 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $16K of PAVmed Inc. Warrant stock for Q1 2018, down 64% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Warrant positions in Q1 2018 and 0 closed out.
- The largest PAVmed Inc. Warrant seller in Q1 2018 was Levin Capital Strategies, an estimated $14.3K sold.
Based on aggregated 13F filings for Q1 2018.